免費(fèi)咨詢熱線：
15522676233
來(lái)那替尼 Neratinib Neratinib, also known as HKI-272 or PB272, is an orally available, irreversible inhibitor of the HER-2 receptor tyrosine kinase with potential antineoplastic activity.
更新時(shí)間：2023-07-12
廠商性質(zhì)：代理商
奧瑞替尼 Osimertinib Osimertinib, also known as AZD-9291 and Mereletinib, is a third-generation EGFR inhibitor,
更新時(shí)間：2023-07-12
廠商性質(zhì)：代理商
達(dá)克替尼 Dacomitinib Dacomitinib, also known as PF-299 and PF-00299804 ; or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor
更新時(shí)間：2023-07-12
廠商性質(zhì)：代理商
吡昔替尼 Pexidartinib Pexidartinib, also know as PLX-3397, is a CSF1R inhibitor with IC50 of 20 nM in development by Plexxikon for the treatment of tenosynovial giant cell tumors.
更新時(shí)間：2023-07-12
廠商性質(zhì)：代理商
瑞博西尼 Ribociclib Ribociclib Free Base, also known as LEE011, is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway,
更新時(shí)間：2023-07-12
廠商性質(zhì)：代理商
